Runben Biotechnology Co., Ltd. (SHA:603193)
China
· Delayed Price · Currency is CNY 26.13
-0.03 (-0.11%)
Apr 29, 2026, 3:00 PM CST
Runben Biotechnology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Operating Revenue | 1,572 | 1,545 | 1,317 | 1,032 | 855.65 | 581.91 | Upgrade
|
| Other Revenue | - | - | 0.77 | 0.66 | 0.44 | 0.24 | Upgrade
|
| Revenue | 1,572 | 1,545 | 1,318 | 1,033 | 856.09 | 582.15 | Upgrade
|
| Revenue Growth (YoY) | 12.96% | 17.19% | 27.61% | 20.66% | 47.06% | 31.46% | Upgrade
|
| Cost of Revenue | 651.69 | 644.04 | 553.2 | 453.34 | 393.28 | 275.75 | Upgrade
|
| Gross Profit | 920.17 | 900.76 | 764.98 | 579.62 | 462.81 | 306.4 | Upgrade
|
| Selling, General & Admin | 531.95 | 521.03 | 411.86 | 301.68 | 257.21 | 155.39 | Upgrade
|
| Research & Development | 38.28 | 37.59 | 35.07 | 25.69 | 19.51 | 13.6 | Upgrade
|
| Other Operating Expenses | 8.68 | 8.27 | 9.39 | 9.42 | 8.77 | 6.83 | Upgrade
|
| Operating Expenses | 578.92 | 566.9 | 456.79 | 336.99 | 285.47 | 175.82 | Upgrade
|
| Operating Income | 341.25 | 333.86 | 308.19 | 242.62 | 177.34 | 130.58 | Upgrade
|
| Interest Expense | - | - | -0.13 | -0.26 | -0.43 | -0.54 | Upgrade
|
| Interest & Investment Income | 19.43 | 19.02 | 34.84 | 16.4 | 7.18 | 6.09 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | - | 0.24 | Upgrade
|
| Other Non Operating Income (Expenses) | 12.18 | 11.03 | -0.13 | -0.05 | -0.16 | -0.05 | Upgrade
|
| EBT Excluding Unusual Items | 372.86 | 363.91 | 342.76 | 258.72 | 183.94 | 136.32 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.57 | 0.84 | 3.59 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.08 | 0.08 | -0.6 | 0.07 | 0.05 | 0 | Upgrade
|
| Asset Writedown | -2.31 | -2.57 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 6.25 | 9.13 | 4.29 | 5.31 | Upgrade
|
| Pretax Income | 369.06 | 362.25 | 352 | 267.93 | 188.27 | 141.63 | Upgrade
|
| Income Tax Expense | 46.12 | 47.75 | 51.84 | 41.9 | 28.23 | 20.98 | Upgrade
|
| Net Income | 322.94 | 314.5 | 300.16 | 226.03 | 160.04 | 120.65 | Upgrade
|
| Net Income to Common | 322.94 | 314.5 | 300.16 | 226.03 | 160.04 | 120.65 | Upgrade
|
| Net Income Growth | 4.55% | 4.78% | 32.80% | 41.23% | 32.66% | 27.38% | Upgrade
|
| Shares Outstanding (Basic) | 404 | 403 | 406 | 353 | 341 | 335 | Upgrade
|
| Shares Outstanding (Diluted) | 404 | 403 | 406 | 353 | 341 | 335 | Upgrade
|
| Shares Change (YoY) | -0.87% | -0.60% | 14.85% | 3.71% | 1.61% | 9.69% | Upgrade
|
| EPS (Basic) | 0.80 | 0.78 | 0.74 | 0.64 | 0.47 | 0.36 | Upgrade
|
| EPS (Diluted) | 0.80 | 0.78 | 0.74 | 0.64 | 0.47 | 0.36 | Upgrade
|
| EPS Growth | 5.47% | 5.41% | 15.63% | 36.17% | 30.56% | 16.13% | Upgrade
|
| Free Cash Flow | 175.92 | 187.42 | 183.02 | 238.87 | 124.67 | -13.38 | Upgrade
|
| Free Cash Flow Per Share | 0.43 | 0.47 | 0.45 | 0.68 | 0.37 | -0.04 | Upgrade
|
| Dividend Per Share | - | - | 0.410 | 0.170 | - | - | Upgrade
|
| Dividend Growth | - | - | 141.18% | - | - | - | Upgrade
|
| Gross Margin | 58.54% | 58.31% | 58.03% | 56.11% | 54.06% | 52.63% | Upgrade
|
| Operating Margin | 21.71% | 21.61% | 23.38% | 23.49% | 20.71% | 22.43% | Upgrade
|
| Profit Margin | 20.54% | 20.36% | 22.77% | 21.88% | 18.70% | 20.72% | Upgrade
|
| Free Cash Flow Margin | 11.19% | 12.13% | 13.88% | 23.13% | 14.56% | -2.30% | Upgrade
|
| EBITDA | 362.26 | 354.59 | 327.81 | 262.46 | 194.59 | 138.59 | Upgrade
|
| EBITDA Margin | 23.05% | 22.95% | 24.87% | 25.41% | 22.73% | 23.81% | Upgrade
|
| D&A For EBITDA | 21.01 | 20.73 | 19.62 | 19.84 | 17.25 | 8.01 | Upgrade
|
| EBIT | 341.25 | 333.86 | 308.19 | 242.62 | 177.34 | 130.58 | Upgrade
|
| EBIT Margin | 21.71% | 21.61% | 23.38% | 23.49% | 20.71% | 22.43% | Upgrade
|
| Effective Tax Rate | 12.50% | 13.18% | 14.73% | 15.64% | 14.99% | 14.82% | Upgrade
|
| Revenue as Reported | - | - | 1,318 | 1,033 | 856.09 | 582.15 | Upgrade
|
| Advertising Expenses | - | - | 320.61 | 218.47 | 187.47 | 107.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.